Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Atsushi Imai is a leading urologic oncologist whose research focuses on optimizing surgical and perioperative management for prostate and bladder cancers, with a particular emphasis on robotic surgery and geriatric oncology. His most impactful work, the 2020 study on the Geriatric 8 screening tool in 540 prostate cancer patients (40 citations), established a critical framework for assessing frailty to guide treatment decisions in older men. Dr. Imai has pioneered advanced robotic techniques, notably the robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer (31 citations), demonstrating improved functional outcomes. He has also made significant contributions to multimodal therapy, comparing neoadjuvant chemohormonal therapy followed by robot-assisted prostatectomy for high-risk disease (13 citations) and evaluating the feasibility of robot-assisted cystectomy after neoadjuvant chemotherapy (12 citations). His work consistently integrates cutting-edge surgical innovation with personalized, risk-adapted care, addressing the complex needs of high-risk and elderly patients. With a growing citation impact and a focus on reproducible outcomes, Dr. Imai is advancing the standard of care in minimally invasive urologic oncology.